FBLG - Company ID 0001958777
FibroBiologics, Inc. trades as FBLG. This page tracks FibroBiologics, Inc. through 209 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-06 |
| Prospectus supplement | 424B5 | 2026-05-06 |
| Major company event | 8-K | 2026-05-05 |
| Annual report to shareholders | ARS | 2026-05-05 |
| Proxy materials | DEFA14A | 2026-05-05 |
| Proxy statement | DEF 14A | 2026-05-05 |
| Insider trade | 4 | 2026-05-04 |
| Insider trade | 4 | 2026-05-04 |
The largest companies sharing FibroBiologics, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year FibroBiologics, Inc. reported a net loss of $18.65M.